A peptide talk between JC virus and the human host: from silent infection to autoimmunity

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 6, 2012, Pages 1067-1074

  Lucchese, Guglielmo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anti JCV vaccine; JCV immunoevasion; JCV latency; JCV associated pathogenesis; JCV versus human peptide commonality

Indexed keywords

PENTAPEPTIDE; POLYPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; HUMAN; IMMUNOREACTIVITY; JC VIRUS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; VIRUS CELL INTERACTION; VIRUS STRAIN;

AUTOIMMUNITY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; JC VIRUS; OLIGOPEPTIDES; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRUS LATENCY;

JC POLYOMAVIRUS;

EID: 84868159600     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2012.686510     Document Type: Article

References (88)

1. Frisque, R.J., Bream, G.L., Cannella, M.T. Human polyomavirus JC virus genome. J Virol 1984, 51, 458-469.
2. Padgett, B.L., Rogers, C.M., Walker, D.L. JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: Additional biological characteristics and antigenic relationships. Infect Immun 1977, 15, 656-662.
3. Berger, J.R., Major, E.O. Progressive multifocal leukoencephalopathy. Semin Neurol 1999, 19, 193-200.
4. Zuckerman, A.J., Banatvala, J.E., Griffiths, P. (2009). Principles and practice of clinical virology. New York: John Wiley & Sons
5. Wen, M.C., Wang, C.L., Wang, M., Cheng, C.H., Wu, M.J., Chen, C.H., Shu, K.H., Chang, D. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol 2004, 72, 675-678.
6. Viallard, J.F., Ellie, E., Lazaro, E., Lafon, M.E., Pellegrin, J.L. JC virus meningitis in a patient with systemic lupus erythematosus. Lupus 2005, 14, 964-966.
7. Boldorini, R., Veggiani, C., Barco, D., Monga, G. Kidney and urinary tract polyomavirus infection and distribution: Molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med 2005, 129, 69-73.
8. Gallia, G.L., Gordon, J., Khalili, K. Tumor pathogenesis of human neurotropic JC virus in the CNS. J Neurovirol 1998, 4, 175-181.
9. Gordon, J., Del Valle, L., Otte, J., Khalili, K. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Oncogene 2000, 19, 4840-4846.
10. Gallia, G.L., DelValle, L., Laine, C., Curtis, M., Khalili, K. Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen. MP, Mol Pathol 2001, 54, 354-359.
11. Enam, S., Del Valle, L., Lara, C., Gan, D.D., Ortiz-Hidalgo, C., Palazzo, J.P., Khalili, K. Association of human polyomavirus JCV with colon cancer: Evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002, 62, 7093-7101.
12. Shin, S.K., Li, M.S., Fuerst, F., Hotchkiss, E., Meyer, R., Kim, I.T., Goel, A., Boland, C.R. Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. Cancer 2006, 107, 481-488.
13. Ramamoorthy, S., Devaraj, B., Miyai, K., Luo, L., Liu, Y.T., Boland, C.R., Goel, A., Carethers, J.M. John Cunningham virus T-antigen expression in anal carcinoma. Cancer 2011, 117, 2379-2385.
14. Dubois, V., Dutronc, H., Lafon, M.E., Poinsot, V., Pellegrin, J.L., Ragnaud, J.M., Ferrer, A.M., Fleury, H.J. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1997, 35, 2288-2292.
15. Andréoletti, L., Dubois, V., Lescieux, A., Dewilde, A., Bocket, L., Fleury, H.J., Wattré, P. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy. AIDS 1999, 13, 1469-1475.
16. Bellizzi, A., Anzivino, E., Ferrari, F., Di Nardo, G., Colosimo, M.T., Fioriti, D., Mischitelli, M., Chiarini, F., Cucchiara, S., Pietropaolo, V. Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. J Neurovirol 2011, 17, 303-313.
17. Weissert, R. Progressive multifocal leukoencephalopathy. J Neuroimmunol 2011, 231, 73-77.
18. Iaffaldano, P., Lucchese, G., Trojano, M. Treating multiple sclerosis with natalizumab. Expert Rev Neurother 2011, 11, 1683-1692.
19. Sariyer, I.K., Khalili, K. Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells. PLoS ONE 2011, 6, e14630.
20. Wollebo, H.S., Safak, M., Del Valle, L., Khalili, K., White, M.K. Role for tumor necrosis factor-a in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol 2011, 233, 46-53.
21. Antonsson, A., Green, A.C., Mallitt, K.A., O'Rourke, P.K., Pawlita, M., Waterboer, T., Neale, R.E. Prevalence and stability of antibodies to the BK and JC polyomaviruses: A long-term longitudinal study of Australians. J Gen Virol 2010, 91, 1849-1853.
22. Kean, J.M., Rao, S., Wang, M., Garcea, R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5, e1000363.
23. Matos, A., Duque, V., Beato, S., da Silva, J.P., Major, E., Meliço-Silvestre, A. Characterization of JC human polyomavirus infection in a Portuguese population. J Med Virol 2010, 82, 494-504.
24. Chesters, P.M., Heritage, J., McCance, D.J. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983, 147, 676-684.
25. Knowles, W.A. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006, 577, 19-45.
26. Kusalik, A., Bickis, M., Lewis, C., Li, Y., Lucchese, G., Marincola, F.M., Kanduc, D. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 2007, 28, 1260-1267.
27. Kanduc, D., Stufano, A., Lucchese, G., Kusalik, A. Massive peptide sharing between viral and human proteomes. Peptides 2008, 29, 1755-1766.
28. Wu, C.H., Yeh, L.S., Huang, H., Arminski, L., Castro-Alvear, J., Chen, Y., Hu, Z., Kourtesis, P., Ledley, R.S., Suzek, B.E., Vinayaka, C.R., Zhang, J., Barker, W.C. The Protein Information Resource. Nucleic Acids Res 2003, 31, 345-347.
29. Capone, G., Novello, G., Fasano, C., Trost, B., Bickis, M., Kusalik, A., Kanduc, D. The oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the noncoding strand. BMC Bioinformatics 2010, 11, 383.
30. Peters, B., Sidney, J., Bourne, P., Bui, H.H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R., Lund, O., Nemazee, D., Ponomarenko, J.V., Sathiamurthy, M., Schoenberger, S., Stewart, S., Surko, P., Way, S., Wilson, S., Sette, A. The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol 2005, 3, e91.
31. Davey, N.E., Edwards, R.J., Shields, D.C. Computational identification and analysis of protein short linear motifs. Front Biosci 2010, 15, 801-825.
32. Li, F., Carlsson, D., Lohmann, C., Suuronen, E., Vascotto, S., Kobuch, K., Sheardown, H., Munger, R., Nakamura, M., Griffith, M. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci USA 2003, 100, 15346-15351.
33. Li, F., Griffith, M., Li, Z., Tanodekaew, S., Sheardown, H., Hakim, M., Carlsson, D.J. Recruitment of multiple cell lines by collagen-synthetic copolymer matrices in corneal regeneration. Biomaterials 2005, 26, 3093-3104.
34. Kim, J.M., Lee, Y.H., Ku, C.R., Lee, E.J. The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice. Endocrinology 2011, 152, 536-544.
35. Kamiya, M., Oyauchi, K., Sato, Y., Yokoyama, T., Wang, M., Aizawa, T., Kumaki, Y., Mizuguchi, M., Imai, K., Demura, M., Suzuki, K., Kawano, K. Structure-activity relationship of a novel pentapeptide with cancer cell growth-inhibitory activity. J Pept Sci 2010, 16, 242-248.
36. Singh, J.P., Tamang, S., Rajamohanan, P.R., Cheng, C.H., Wu, M.J., Chen, C.H., Shu, K.H., Chang, D. Isolation, structure, and functional elucidation of a modified pentapeptide, cysteine protease inhibitor (CPI-2081) from Streptomyces species 2081 that exhibit inhibitory effect on cancer cell migration. J Med Chem 2010, 53, 5121-5128.
37. Girnys, E.A., Sobczyk-Kojiro, K., Mosberg, H.I. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19. Chem Biol Drug Des 2010, 75, 35-39.
38. Leali, D., Bianchi, R., Bugatti, A., Nicoli, S., Mitola, S., Ragona, L., Tomaselli, S., Gallo, G., Catello, S., Rivieccio, V., Zetta, L., Presta, M. Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide. J Cell Mol Med 2010, 14, 2109-2121.
39. Landsteiner, K., van der Scheer, J. On the serological specificity of peptides. III. J Exp Med 1939, 69, 705-719.
40. Lucchese, G., Stufano, A., Trost, B., Kusalik, A., Kanduc, D. Peptidology: Short amino acid modules in cell biology and immunology. Amino Acids 2007, 33, 703-707.
41. Tassi, G.C., Valcurone, G. [Atopy and RAST. Diagnostic, therapeutic and standardization problems. Experimental contribution (allergy to antibiotics)]. Boll Ist Sieroter Milan 1978, 57, 557-574.
42. Cohen, G.A., O'Connor, R.D., Hamburger, R.N. Safety and efficacy of human IgE pentapeptide. Ann Allergy 1984, 52, 83-86.
43. Marone, G., Columbo, M., Soppelsa, L., Condorelli, M. The mechanism of basophil histamine release induced by pepstatin A. J Immunol 1984, 133, 1542-1546.
44. Hobbs, M.V., Morgan, E.L., Houghten, R.A., Thoman, M.L., Weigle, W.O. Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1. J Immunol 1987, 138, 2581-2586.
45. Zagury, J.F., Lachgar, A., Achour, A., Chams-Harvey, V., Cho, Y.Y., Le Coq, H., Bizzini, B., Feldman, M., Burny, A., Zagury, D. Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed Pharmacother 1994, 48, 11-16.
46. Abe, T., Satoh, N., Nakajima, A., Koizumi, T., Tamada, M., Sakuragi, S. Characterization of a potent uveitopathogenic site derived from rat phosducin. Exp Eye Res 1997, 65, 703-710.
47. Tanabe, S. Epitope peptides and immunotherapy. Curr Protein Pept Sci 2007, 8, 109-118.
48. Lucchese, G., Calabro, M., Kanduc, D. Circumscribing the conformational peptide epitope landscape. Curr Pharm Des 2012, 18, 832-839.
49. Lucchese, G., Sinha, A.A., Kanduc, D. How a single amino acid change may alter the immunological information of a peptide. Front Biosci (Elite Ed) 2012, 4, 1843-1852.
50. Cubitt, C.L., Cui, X., Agostini, H.T., Nerurkar, V.R., Scheirich, I., Yanagihara, R., Ryschkewitsch, C.F., Stoner, G.L. Predicted amino acid sequences for 100 JCV strains. J Neurovirol 2001, 7, 339-344.
51. Du Pasquier, R.A., Kuroda, M.J., Schmitz, J.E., Zheng, Y., Martin, K., Peyerl, F.W., Lifton, M., Gorgone, D., Autissier, P., Letvin, N.L., Koralnik, I.J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A.*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol 2003, 77, 11918-11926.
52. Li, J., Melenhorst, J., Hensel, N., Rezvani, K., Sconocchia, G., Kilical, Y., Hou, J., Curfman, B., Major, E., Barrett, A.J. T-cell responses to peptide fragments of the BK virus T antigen: Implications for crossreactivity of immune response to JC virus. J Gen Virol 2006, 87, 2951-2960.
53. Sharma, M.C., Zhou, W., Martinez, J., Krymskaya, L., Srivastava, T., Haq, W., Diamond, D.J., Lacey, S.F. Cross-reactive CTL recognizing two HLA-A.*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology 2006, 350, 128-136.
54. Chen, Y., Trofe, J., Gordon, J., Autissier, P., Woodle, E.S., Koralnik, I.J. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A.*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008, 42, 198-202.
55. Lima, M.A., Marzocchetti, A., Autissier, P., Tompkins, T., Chen, Y., Gordon, J., Clifford, D.B., Gandhi, R.T., Venna, N., Berger, J.R., Koralnik, I.J. Frequency and phenotype of JC virus-specific CD8+T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007, 81, 3361-3368.
56. Mao, Y.S., Lu, C.Z., Wang, X., Xiao, B.G. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Exp Neurol 2007, 206, 231-239.
57. Ramaswami, B., Popescu, I., Macedo, C., Luo, C., Shapiro, R., Metes, D., Chalasani, G., Randhawa, P.S. The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol 2011, 18, 815-824.
58. Lucchese, G., Stufano, A., Kanduc, D. Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol Med Microbiol 2009, 57, 88-92.
59. Kanduc, D., Tessitore, L., Lucchese, G., Kusalik, A., Farber, E., Marincola, F.M. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immunother 2008, 57, 1215-1223.
60. Polimeno, L., Mittelman, A., Gennero, L., Ponzetto, A., Lucchese, G., Stufano, A., Kusalik, A., Kanduc, D. Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids 2008, 34, 479-484.
61. Yan, H.X., Yang, W., Zhang, R., Chen, L., Tang, L., Zhai, B., Liu, S.Q., Cao, H.F., Man, X.B., Wu, H.P., Wu, M.C., Wang, H.Y. Proteintyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J Biol Chem 2006, 281, 15423-15433.
62. Makoukji, J., Shackleford, G., Meffre, D., Grenier, J., Liere, P., Lobaccaro, J.M., Schumacher, M., Massaad, C. Interplay between LXR and Wnt/ß-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols. J Neurosci 2011, 31, 9620-9629.
63. Seeling, J.M., Miller, J.R., Gil, R., Moon, R.T., White, R., Virshup, D.M. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 1999, 283, 2089-2091.
64. Chen, Y., Trofe, J., Gordon, J., Du Pasquier, R.A., Roy-Chaudhury, P., Kuroda, M.J., Woodle, E.S., Khalili, K., Koralnik, I.J. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006, 80, 3495-3505.
65. Krymskaya, L., Sharma, M.C., Martinez, J., Haq, W., Huang, E.C., Limaye, A.P., Diamond, D.J., Lacey, S.F. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005, 79, 11170-11178.
66. Ibi, D., Nitta, A., Ishige, K., Cen, X., Ohtakara, T., Nabeshima, T., Ito, Y. Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region. Neurochem Int 2010, 56, 77-83.
67. Hashida, H., Goto, J., Zhao, N., Takahashi, N., Hirai, M., Kanazawa, I., Sakaki, Y. Cloning and mapping of ZNF231, a novel brainspecific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). Genomics 1998, 54, 50-58.
68. Parfitt, D.A., Michael, G.J., Vermeulen, E.G., Prodromou, N.V., Webb, T.R., Gallo, J.M., Cheetham, M.E., Nicoll, W.S., Blatch, G.L., Chapple, J.P. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum Mol Genet 2009, 18, 1556-1565.
69. Koralnik, I.J., Du Pasquier, R.A., Kuroda, M.J., Schmitz, J.E., Dang, X., Zheng, Y., Lifton, M., Letvin, N.L. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 2002, 168, 499-504.
70. Matsuoka, H., Obama, H., Kelly, M.L., Matsui, T., Nakamoto, M. Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration. J Biol Chem 2005, 280, 29355-29363.
71. Matsuoka, H., Iwata, N., Ito, M., Shimoyama, M., Nagata, A., Chihara, K., Takai, S., Matsui, T. Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun 1997, 235, 487-492.
72. Cholay, M., Reverdy, C., Benarous, R., Colland, F., Daviet, L. Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase. Exp Cell Res 2010, 316, 667-675.
73. Miller, C.L., Burkhardt, A.L., Lee, J.H., Stealey, B., Longnecker, R., Bolen, J.B., Kieff, E. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995, 2, 155-166.
74. Perides, G., Rahemtulla, F., Lane, W.S., Asher, R.A., Bignami, A. Isolation of a large aggregating proteoglycan from human brain. J Biol Chem 1992, 267, 23883-23887.
75. Dours-Zimmermann, M.T., Maurer, K., Rauch, U., Stoffel, W., Fässler, R., Zimmermann, D.R. Versican V2 assembles the extracellular matrix surrounding the nodes of ranvier in the CNS. J Neurosci 2009, 29, 7731-7742.
76. Melendez-Vasquez, C., Carey, D.J., Zanazzi, G., Reizes, O., Maurel, P., Salzer, J.L. Differential expression of proteoglycans at central and peripheral nodes of Ranvier. Glia 2005, 52, 301-308.
77. Du Pasquier, R.A., Stein, M.C., Lima, M.A., Dang, X., Jean-Jacques, J., Zheng, Y., Letvin, N.L., Koralnik, I.J. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J Neuroimmunol 2006, 176, 181-186.
78. Reddehase, M.J., Rothbard, J.B., Koszinowski, U.H. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 1989, 337, 651-653.
79. Hemmer, B., Kondo, T., Gran, B., Pinilla, C., Cortese, I., Pascal, J., Tzou, A., McFarland, H.F., Houghten, R., Martin, R. Minimal peptide length requirements for CD4(+) T cell clonesYimplications for molecular mimicry and T cell survival. Int Immunol 2000, 12, 375-383.
80. Rothbard, J.B., Gefter, M.L. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 1991, 9, 527-565.
81. Tiwari, R., Geliebter, J., Lucchese, A., Mittelman, A., Kanduc, D. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides 2004, 25, 1865-1871.
82. Lucchese, G., Stufano, A., Kanduc, D. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis. J Biomed Biotechnol 2010, 2010, 832341.
83. Kanduc, D. The self/nonself issue: A confrontation between proteomes. Self Nonself 2010, 1, 255-258.
84. Kanduc, D. Peptide cross-reactivity: The original sin of vaccines. Front Biosci 2012, 4, 1393-1401.
85. Lucchese, G. Confronting JC virus and Homo sapiens biological signatures. Front Biosci 2012, in press
86. Lucchese, G., Stufano, A., Calabro, M., Kanduc, D. Charting the peptide crossreactome between HIV-1 and the human proteome. Front Biosci (Elite Ed) 2011, 3, 1385-1400.
87. Lucchese, G., Stufano, A., Kanduc, D. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. Self Nonself 2011, 2, 49-54.
88. Lucchese, G., Pesce Delfino, A. Using proteomics to develop an anti-Campylobacter jejuni vaccine. Immunopharmacol Immunotoxicol 2012. doi:10.3109/08923973.2011.608685